Please turn JavaScript on
consumerchoicecenter icon

consumerchoicecenter

Receive updates from Consumerchoicecenter for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on Specificfeeds.

This way you won't miss any new article from Consumerchoicecenter. Unsubscribe at any time.

Site title: Home - Consumer Choice Center

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.82 / day

Message History

Lawmakers in Colorado want to make life more affordable, but their latest credit card bill will do the complete opposite. The bill, SB26-134, passed by the House and Senate of the Colorado General Assembly, prohibits card networks from charging fees on the sales tax portion of a transaction. While this may sound good on the surface, it’s anything but. It bans Visa, Mastercard...


Read full story

In an Oval Office press conference in his usual flair yesterday, President Donald Trump vowed to “approve” natural 7-OH: This makes a stark contrast from July of last year, when Trump’s Secretary of Health and Human Services, Robert F. Kennedy, Jr., and his FDA Commissioner Marty Makary called on the DEA to make 7-OH a Schedule One narcotic. Now, it seems their boss is taking...


Read full story

WASHINGTON, D.C. — According to a new report in the Wall Street Journal, “President Trump has signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary, according to people familiar with the matter, following a tumultuous period for the regulator that included clashes over vaping, abortion and drug policy.” Top members of the administration have beco...


Read full story

After Americans consumed roughly 2 billion servings of 7-hydroxymitragynine (7-OH) since 2023, the FDA’s adverse event database logged about 100 reports. That works out to one event per 20 million servings, fewer than the agency receives about ordinary soap. Yet the FDA Commissioner Marty Makary now wants the DEA to list 7-OH alongside heroin and LSD as a Schedule I narcotic…...


Read full story

The National Consumers League’s new issue brief is a useful and uncomfortable reminder that a program created to help vulnerable patients can drift far from its mission. Its core finding is simple: many 340B hospitals, despite benefiting from discounted outpatient drugs, are more likely than non-340B hospitals to maintain aggressive medical debt collection policies. That shou...


Read full story